decisionhealth Newsletters, Answer Books - 2007 Issue 10 (October)
Answer_Book / Drugs_Injections / Drugs_for_toxicity_of_cancer_treatment
Subscribe or sign in to view the full article.
Article Overview
This premium article addresses billing and reimbursement considerations for drugs used to treat toxicities or side effects related to cancer therapy when given in connection with chemotherapy treatment. It is aimed at clinicians, coders, and billing staff who need a broad understanding of Medicare support sources, acceptable medical literature, and documentation considerations for drug reimbursement review.
Why This Topic Matters
Understanding these coverage topics can help billing and reimbursement teams recognize when supportive drugs related to cancer treatment may be eligible for payment review and what kinds of medical references are discussed by Medicare policy.
What You Will Learn
- How the article frames coverage for drugs used in connection with cancer treatment toxicities
- Which categories of medical literature are discussed as support for reimbursement review
- Why supporting documentation may be relevant when submitting claims for these drugs
- How the article situates Medicare reimbursement guidance for cancer regimen drugs
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle teams
- Oncology practices
- Physicians
- Compliance staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com